INHIBITION OF HUMAN-PLATELET THROMBOXANE GENERATION BY ASPIRIN IN THE ABSENCE OF MEASURABLE DRUG LEVELS IN PERIPHERAL-BLOOD

被引：29

作者：

CERLETTI, C

LATINI, R

DEJANA, E

TOGNONI, G

GARATTINI, S

DEGAETANO, G

机构：

来源：

BIOCHEMICAL PHARMACOLOGY | 1985年 / 34卷 / 10期

关键词：

D O I：

10.1016/0006-2952(85)90658-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1839 / 1841

页数：3

共 27 条

[1] PLASMA ACETYLSALICYLATE AND SALICYLATE AND PLATELET CYCLOOXYGENASE ACTIVITY FOLLOWING PLAIN AND ENTERIC-COATED ASPIRIN [J].

ALI, M ;

MCDONALD, JWD ;

THIESSEN, JJ ;

COATES, PE .

STROKE, 1980, 11 (01) :9-13

[2] CULTURED HUMAN-SKIN FIBROBLASTS AND ARTERIAL CELLS PRODUCE A LABILE PLATELET-INHIBITORY PROSTAGLANDIN [J].

BAENZIGER, NL ;

DILLENDER, MJ ;

MAJERUS, PW .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1977, 78 (01) :294-301

[3] PLATELET THROMBOXANE SYNTHETASE INHIBITORS WITH LOW-DOSES OF ASPIRIN - POSSIBLE RESOLUTION OF THE ASPIRIN DILEMMA [J].

BERTELE, V ;

FALANGA, A ;

TOMASIAK, M ;

DEJANA, E ;

CERLETTI, C ;

DEGAETANO, G .

SCIENCE, 1983, 220 (4596) :517-519

[4]

BONATI M, 1979, J CHROMATOGR, V164, P109

[5] BIOAVAILABILITY OF ACETYLSALICYLIC-ACID AND SALICYLIC-ACID FROM RAPID-RELEASE AND SLOW-RELEASE FORMULATIONS, AND IN COMBINATION WITH DIPYRIDAMOL [J].

BRANTMARK, B ;

WAHLINBOLL, E ;

MELANDER, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (04) :309-314

[6] DIFFERENCES IN INHIBITION OF PGI2 PRODUCTION BY ASPIRIN IN RABBIT ARTERY AND VEIN SEGMENTS [J].

BUCHANAN, MR ;

DEJANA, E ;

CAZENAVE, JP ;

RICHARDSON, M ;

MUSTARD, JF ;

HIRSH, J .

THROMBOSIS RESEARCH, 1980, 20 (04) :447-460

[7] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS REACT WITH 2 SITES ON PLATELET CYCLO-OXYGENASE - EVIDENCE FROM INVIVO DRUG-INTERACTION STUDIES IN RATS [J].

CERLETTI, C ;

LIVIO, M ;

DEGAETANO, G .

BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 714 (01) :122-128

[8]

CERLETTI C, 1984, J LAB CLIN MED, V103, P869

[9]

DEGAETANO G, 1982, LANCET, V2, P974

[10] SALICYLATE-ASPIRIN INTERACTION IN THE RAT - EVIDENCE THAT SALICYLATE ACCUMULATING DURING ASPIRIN ADMINISTRATION MAY PROTECT VASCULAR PROSTACYCLIN FROM ASPIRIN-INDUCED INHIBITION [J].

DEJANA, E ;

CERLETTI, C ;

DECASTELLARNAU, C ;

LIVIO, M ;

GALLETTI, F ;

LATINI, R ;

DEGAETANO, G .

JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (04) :1108-1112

← 1 2 3 →